Contact
Please use this form to send email to PR contact of this press release:
KYAN Technologies to Present New Data on Optim.AI™ Immunotherapy and Real-World Pan-Cancer Utility at AACR 2025
TO:
For media inquiries contact:
Sudha Sruthi, Corporate Development